Premium
Clinical and immunological characterization of 14 cases of dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid: a single‐centre study
Author(s) -
Hayashi M.,
Tsunoda T.,
Sato F.,
Yaguchi Y.,
Igarashi M.,
Izumi K.,
Nishie W.,
Ishii N.,
Okamura K.,
Suzuki T.,
Hashimoto T.
Publication year - 2020
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.18516
Subject(s) - bullous pemphigoid , dipeptidyl peptidase 4 inhibitor , dipeptidyl peptidase 4 , dipeptidyl peptidase , medicine , pemphigoid , dermatology , immunology , chemistry , enzyme , diabetes mellitus , antibody , endocrinology , biochemistry , type 2 diabetes mellitus , type 2 diabetes
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom